Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: A023910)
Health Care · Pharmaceuticals · KR
₩26,500.00
+1.53% today · -10.9% 1Y
Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: A023910) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $112.62M.
Over the last twelve months the share price has lost 10.9%, trading between 24.00K and 31.70K.
Tweenvest scores Daihan Pharmaceutical Co.,Ltd. across four factors: quality 84/100, value 79/100, growth 23/100. Its strongest factor is quality.
A023910 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $112.62M
- Revenue (TTM)
- $138.90M
- P/E
- 5.78
- EPS
- 4,588.16
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- ₩31,700.00
- 52-week low
- ₩24,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.88M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.58 | +0.05% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.39 | -0.60% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.23 | +0.38% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.